Together, these results demonstrate that PTGES3 is required for AR levels and activity, is conditionally essential in diverse AR-driven PCa models but not in non-AR-driven cancer cells and is associated with poor prognosis in PCa patients. Here, PTGES3 is linked to posterior cortical atrophy.